Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,463 signal articles · 162 in last 24h · 116,475 total before filter · latest 19m ago
162last 24h
1725last 7d
283● bullish (7d)
155● bearish (7d)
205publishers
AllMacro319Earnings782M&A102Regulatory25Product16Analyst23
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Meta's Open-Source AI Bet Could Be A Problem For OpenAI, Anthropic
Benzinga Private Markets6d agoneutral
Meta's Open-Source AI Bet Could Be A Problem For OpenAI, Anthropic

Meta Platforms Inc. (NASDAQ:META) is betting that powerful AI should become abundant and inexpensive — a vision that could put pressure on the enormous valuations of OpenAI and Anthropic. In a 6,500-word manifesto published Monday, Mark Zuckerberg argued that AI...

Curreen Capital: TriNet (TNET) is a “Crazy-Cheap” Turnaround
Insider Monkey6d agoneutral
Curreen Capital: TriNet (TNET) is a “Crazy-Cheap” Turnaround

Investment management company Curreen Capital released its second-quarter 2026 Investor letter. A copy of the letter can be downloaded here. In the second quarter, the fund returned 22.26% compared to 15.20% for the S&P 500 Index. The performance was driven by active special case investments, including buying a tender offer, a merger-spinoff, and investments in […]

Google faces French media complaint over AI-generated article summaries
InvestorsHub6d agoneutral
Google faces French media complaint over AI-generated article summaries

French media organisations have asked France’s competition regulator to intervene over Google’s (NASDAQ:GOOG) use of artificial intelligence to generate summaries of news articles, according to a press trade association body. The publishers argue that Google’s AI-generated summaries are reducing the number of users clicking through to their websites, potentially weakening an important source of traffic for traditional media companies.

Rocket Lab May Not Launch New Rocket This Year, Hitting Shares
The Wall Street Journal6d agoneutral
Rocket Lab May Not Launch New Rocket This Year, Hitting Shares

Shares of Rocket Lab traded down more than 4% premarket after the company indicated its forthcoming Neutron vehicle may not be ready to launch this year. The company said Monday it is planning to deliver the first Neutron rocket to a launch pad in the last quarter of 2026. In May, Rocket Lab said it was in position to debut the rocket this year.

Bloomberg6d agobullish
Buying Opportunity Forms Around S&P Skeptics’ Refusal to Give Up

(Bloomberg) -- US stocks may be sitting at a record, but anxiety about everything from geopolitics to inflation and a divided Federal Reserve is keeping animal spirits at bay. And that may be just what the rally needs to continue. Most Read from BloombergChina Unleashes $28 Trillion Capital Markets to Challenge US in AINvidia Taps Wall Street for $500 Billion Funding CommitmentFive Takeaways From Zuckerberg’s 6,500-Word Manifesto on AITrump Makes Sweeping New Demands on Iran as Deal Hopes DimSto

Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market?
Insider Monkey6d agoneutral
Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market?

The duopoly dominating the multi-billion-dollar GLP-1 weight-loss market has moved from pharmacy shelves to the federal courtroom. Novo Nordisk A/S (NYSE:NVO) filed a lawsuit in U.S. District Court in New Jersey against Eli Lilly and Company (NYSE:LLY) on July 21, accusing its primary rival of false advertising and unfair competition regarding television and digital campaigns […]

Operational Recovery Positions Advance Auto Parts (AAP) for Gains
Insider Monkey6d agoneutral
Operational Recovery Positions Advance Auto Parts (AAP) for Gains

Investment management company Curreen Capital released its second-quarter 2026 Investor letter. A copy of the letter can be downloaded here. In the second quarter, the fund returned 22.26% compared to 15.20% for the S&P 500 Index. The performance was driven by active special case investments, including buying a tender offer, a merger-spinoff, and investments in […]

Cloud AI Today - Novo Nordisk Partners With AWS For AI-Driven Drug Discovery
Simply Wall St.6d agoneutral
Cloud AI Today - Novo Nordisk Partners With AWS For AI-Driven Drug Discovery

Novo Nordisk has entered a strategic partnership with Amazon Web Services (AWS) to enhance drug discovery using artificial intelligence and cloud technologies. This collaboration includes establishing a co-innovation hub in London, which brings together AWS engineers, AI specialists, and Novo Nordisk's research and development teams to streamline the process of bringing new medicines to market. As part of this agreement, AWS becomes Novo Nordisk's preferred cloud provider and strategic AI...